Core Viewpoint - Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. has approved its 2024 annual equity distribution plan during the shareholders' meeting held on June 3, 2025, emphasizing its commitment to shareholder returns [1] Summary by Relevant Sections Equity Distribution Plan - The equity distribution plan includes a record date of June 18, 2025, and the ex-dividend date and cash dividend payment date are both set for June 19, 2025 [1] - The distribution is targeted at A-share shareholders registered with China Securities Depository and Clearing Corporation Limited in Shanghai as of the close of trading on the record date [1] Taxation Details - Individual shareholders and securities investment funds holding shares for over one year are exempt from personal income tax, while those holding for one month to one year are taxed at a rate of 10%, and those holding for less than one month are taxed at 20% [1] - Qualified Foreign Institutional Investors (QFII) and investors through the Shanghai-Hong Kong Stock Connect are subject to a 10% tax rate [1] Shareholder Engagement - The dividend plan reflects the company's focus on returning value to shareholders and aligns with relevant tax policy requirements [1] - Investors are advised to pay attention to the record date and tax treatment details to ensure the smooth realization of their rights [1]